Breaking news in spinal cord injury research FDA approved phase I clinical trial of human, autologous Schwann cell transplantation in patients with spinal cord injuries

Research output: Contribution to journalEditorial

5 Scopus citations

Fingerprint Dive into the research topics of 'Breaking news in spinal cord injury research FDA approved phase I clinical trial of human, autologous Schwann cell transplantation in patients with spinal cord injuries'. Together they form a unique fingerprint.